208 related articles for article (PubMed ID: 18628455)
21. Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells.
Bhatia B; Tang S; Yang P; Doll A; Aumüeller G; Newman RA; Tang DG
Oncogene; 2005 May; 24(22):3583-95. PubMed ID: 15750631
[TBL] [Abstract][Full Text] [Related]
22. Expression of genes involved in the regulation of p16 in psoriatic involved skin.
Mark EB; Jonsson M; Asp J; Wennberg AM; Mölne L; Lindahl A
Arch Dermatol Res; 2006 Apr; 297(10):459-67. PubMed ID: 16552541
[TBL] [Abstract][Full Text] [Related]
23. Intermediate basal cells of the prostate: in vitro and in vivo characterization.
Garraway LA; Lin D; Signoretti S; Waltregny D; Dilks J; Bhattacharya N; Loda M
Prostate; 2003 May; 55(3):206-18. PubMed ID: 12692787
[TBL] [Abstract][Full Text] [Related]
24. The senescence pathway in prostatic carcinogenesis.
Sharma S; Shin JS; Grimshaw M; Clarke RA; Lee CS
Pathology; 2010; 42(6):507-11. PubMed ID: 20854067
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.
Jiborn T; Abrahamson M; Gadaleanu V; Lundwall A; Bjartell A
BJU Int; 2006 Jul; 98(1):189-96. PubMed ID: 16831167
[TBL] [Abstract][Full Text] [Related]
26. E2F-1 is a critical modulator of cellular senescence in human cancer.
Park C; Lee I; Kang WK
Int J Mol Med; 2006 May; 17(5):715-20. PubMed ID: 16596252
[TBL] [Abstract][Full Text] [Related]
27. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
[TBL] [Abstract][Full Text] [Related]
28. JunB is a gatekeeper for B-lymphoid leukemia.
Ott RG; Simma O; Kollmann K; Weisz E; Zebedin EM; Schorpp-Kistner M; Heller G; Zöchbauer S; Wagner EF; Freissmuth M; Sexl V
Oncogene; 2007 Jul; 26(33):4863-71. PubMed ID: 17297445
[TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
30. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
Shen WJ; Dai DQ; Teng Y; Liu J
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
Zhou Z; Flesken-Nikitin A; Nikitin AY
Cancer Res; 2007 Jun; 67(12):5683-90. PubMed ID: 17553900
[TBL] [Abstract][Full Text] [Related]
32. Expression of prothymosin alpha is correlated with development and progression in human prostate cancers.
Suzuki S; Takahashi S; Takahashi S; Takeshita K; Hikosaka A; Wakita T; Nishiyama N; Fujita T; Okamura T; Shirai T
Prostate; 2006 Apr; 66(5):463-9. PubMed ID: 16353248
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers.
Singh A; Jones RF; Friedman H; Hathir S; Soos G; Zabo A; Haas GP
Anticancer Res; 1999; 19(6B):5415-7. PubMed ID: 10697570
[TBL] [Abstract][Full Text] [Related]
34. cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
Cantile M; Kisslinger A; Cindolo L; Schiavo G; D'Antò V; Franco R; Altieri V; Gallo A; Villacci A; Tramontano D; Cillo C
J Cell Physiol; 2005 Nov; 205(2):202-10. PubMed ID: 15895411
[TBL] [Abstract][Full Text] [Related]
35. Function of heparanase in prostate tumorigenesis: potential for therapy.
Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
[TBL] [Abstract][Full Text] [Related]
36. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
[TBL] [Abstract][Full Text] [Related]
37. Senescence and immortality in hepatocellular carcinoma.
Ozturk M; Arslan-Ergul A; Bagislar S; Senturk S; Yuzugullu H
Cancer Lett; 2009 Dec; 286(1):103-13. PubMed ID: 19070423
[TBL] [Abstract][Full Text] [Related]
38. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
[TBL] [Abstract][Full Text] [Related]
39. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
DeInnocentes P; Agarwal P; Bird RC
J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
